Live
- Sudanese army recaptures capital of Sinnar State in central Sudan
- Kishkindha Kaandam Review: Some movies prove not to compromise in having a good cinematic experience and this is one of them
- Son-rise: Hemant Soren grows taller as tribal leader, makes father proud
- ISL 2024-25: 10-man NorthEast United FC hold on to take three points vs Punjab FC
- BGT 2024-25: Jaiswal’s application, commitment to form a partnership was so impressive, says Gilchrist
- BGT 2024-25: Personally, I am very happy with my performance, says Harshit Rana
- Pakistan's Lahore remains world's most polluted city despite light drizzle
- Asha Nautiyal retains Kedarnath for BJP, to be back as MLA after 12 years
- India leads world in science, innovation research: Minister
- Flash flood in Indonesia's South Tapanuli claims two lives
New Delhi: Biocon Q3 net dips 7%
Highlights
Biotechnology major Biocon on Thursday reported a 6.62 per cent fall in consolidated net profit at Rs 202.8 crore for the quarter ended December 31, 2019 due to higher research and development (R&D) expenses and tax impact of an exceptional item.
New Delhi: Biotechnology major Biocon on Thursday reported a 6.62 per cent fall in consolidated net profit at Rs 202.8 crore for the quarter ended December 31, 2019 due to higher research and development (R&D) expenses and tax impact of an exceptional item.
The company had posted a net profit of Rs 217.2 crore during October-December period of the previous fiscal, Biocon said in a filing to the BSE. The company's consolidated revenue from operations, however, rose to Rs 1,748.1 crore for the quarter under consideration as against Rs 1,540.8 crore in the same period a year ago. Its expenses rose to Rs 1,465.6 crore for the quarter ended December 2019 as against Rs 1,295.4 crore in the year-ago period.
Next Story
ADVERTISEMENT
